Moxidox (Moxifloxacin)

Moxifloxacin, the active ingredient in Moxidox, is a fluoroquinolone antibiotic presented as an oral tablet for oral use. It treats a variety of bacterial infections in adult patients, including community‑acquired bacterial pneumonia, acute bacterial sinusitis, chronic bronchitis exacerbations, complicated skin‑structure infections and intra‑abdominal infections.

GNH USA supplies Moxidox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers, with a focus on timely delivery and regulatory compliance.

Moxidox (moxifloxacin) is a fluoroquinolone antibiotic used to treat bacterial infections in several organ systems.

- Community‑acquired bacterial pneumonia: effective eradication of the causative pathogens. - Acute bacterial sinusitis: rapid resolution of sinus inflammation and infection. - Acute bacterial exacerbation of chronic bronchitis: reduces bacterial load and improves respiratory function. - Complicated skin and skin‑structure infections: clears infection in deep or extensive skin lesions. - Intra‑abdominal infections: treats polymicrobial infections within the abdominal cavity.

Moxidox may cause adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness

Serious or Rare Side Effects: - Tendon rupture or inflammation - QT interval prolongation leading to cardiac arrhythmias - Severe allergic reactions, including anaphylaxis and Stevens‑Johnson syndrome

When prescribing Moxidox, clinicians should consider the following precautions. - Renal impairment: assess renal function and adjust therapy if needed. - History of tendon disorders: avoid use in patients with prior tendon injury. - Cardiac arrhythmias: monitor QT interval, especially in patients with known risk factors. - Concomitant QT‑prolonging drugs: avoid or use with caution. - Elderly patients: increased risk of adverse events, monitor closely. - Store at below 25°C: keep in the original pack, protect from moisture.

Moxidox can interact with other medicines; notable interactions are grouped by clinical significance.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce moxifloxacin absorption. - Warfarin: may increase anticoagulant effect and bleeding risk. - Cyclosporine: can raise moxifloxacin plasma concentrations.

Moderate Interactions (Monitor Closely): - NSAIDs: potential for central nervous system stimulation. - Theophylline: may increase theophylline plasma levels, requiring dose adjustment.